BrightSpring Health Services, I

Valuation Analysis

About the Company

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. B

BrightSpring Health Services, I Stock at a Glance

BrightSpring Health Services, I (BTSG) is currently trading at $63.23 with a market capitalization of $12.4B. The trailing P/E ratio stands at 82.12x, with a forward P/E of 29.92x. The 52-week range spans from $19.01 to $64.18; the current price is 1.5% below the yearly high. Year-over-year revenue growth stands at +25.6%. The net profit margin stands at 2.27%.

💰 Dividend

BrightSpring Health Services, I currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

16 analysts rate BrightSpring Health Services, I (BTSG) on consensus: Strong Buy. The average price target is $62.56, implying -1.06% from the current price. Analyst price targets range from $49.00 to $71.00.

BrightSpring Health Services, I: The Investment Case in Detail

BrightSpring Health Services, I (BTSG) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Top-line momentum is unusually strong with revenue expanding 25.6% year-over-year, a pace that puts the company well above the market average and signals genuine demand traction rather than mere cyclical tailwind.

The Bear Case

With a net margin of just 2.27%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. With a beta near 1.87, the share price moves sharply more than the broader market — drawdowns in market corrections can be unusually severe and require strong nerves. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valuation in Context

The EV/EBITDA multiple of 26.81x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

What to Watch Next

• The forward P/E of 29.92x is meaningfully below the trailing 82.12x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 97.9% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to above-average price swings, elevated short interest (6.98%), higher leverage relative to equity.

Trading Data

Related Stocks in the Same Sector

Where can I buy BrightSpring Health Services, I?

Compare top-rated brokers — low fees, trusted providers, fully regulated.